ResearcherWuhan University of Science and TechnologyActive in the last 2 years

Yifeng Liu

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0009-0005-9645-0130; OpenAlex author ID A5101814990.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 1

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

LINC00847 drives pancreatic cancer progression by targeting the miR-455-3p/HDAC4 axis. Last author DOI 10.5114/aoms/171672 ↗
Hsa_circ_0000106 Acts as a Tumor Promoter in Pancreatic Cancer by Targeting the MiR-455-3p/HDAC4. Last author DOI 10.1055/a-2125-7018 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Shunxin Hao · 2 shared papers, 2023–2024
- Paper LINC00847 drives pancreatic cancer progression by targeting the miR-455-3p/HDAC4 axis. DOI 10.5114/aoms/171672 ↗
- Paper Hsa_circ_0000106 Acts as a Tumor Promoter in Pancreatic Cancer by Targeting the MiR-455-3p/HDAC4. DOI 10.1055/a-2125-7018 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.